Am-Pharma is a startup based in the Netherlands, 4 tracked investors.
Am-Pharma is a startup founded in 2002 based in the Netherlands. Brouky records 4 investors associated with the company.
Am-Pharma develops ilofotase alfa, a recombinant human alkaline phosphatase enzyme replacement therapy targeting hypophosphatasia (HPP), a rare genetic metabolic disorder, to improve bone mineralization and address related symptoms in adult patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.